The global CBD pet market size was estimated at USD 248.39 million in 2023 and is expected to grow at a CAGR of 32.47% from 2024 to 2030. The market is primarily driven by several factors such as rising R&D initiatives, increasing awareness & sales of cannabidiol (CBD) pet products, and growing pet humanization & pet expenditure. Pet owners spend their money on several items, such as pharmaceuticals, vitamins, foods/treats, and over-the-counter drugs. Pet parents are spending significantly on CBD products due to their perceived benefits.
Pet parents spend money on CBD products to keep their beloved companions happy and healthy. According to Hemp Industry Daily (Anne Holland Ventures, Inc.), the market is growing and has increased from nearly 0 to USD 25 million from 2016 to 2019. Moreover, it might increase to USD 225 million by 2025. If the FDA authorizes the use & more mainstream shops and veterinarians adopting this category, hemp-CBD products might represent one in every four animal health supplements by 2025. As per the same source, dog and cat owners spend about USD 24 and USD 21 respectively on hemp CBD products annually. Therefore, growing awareness among pet owners is widely contributing to its sales growth, which boosts the opportunity in the market.
The research activities for hemp and CBD-based products have significantly evolved in veterinary medicine in the last decade, which has provided clinical evidence supporting the benefits of hemp on the health of companion animals. The clinical efficacy is constantly studied to better understand the pharmacokinetic properties of CBD in animal metabolism and overall health. Such research studies are unveiling several notable treatment applications of CBD-based products in dogs and cats.
The CBD pet market is highly fragmented. The market is at a high growth stage, and the rate of expansion is accelerating. Rapid developments in veterinary diagnostics, as well as increased R&D expenditure by leading players, are key drivers of market growth. Market concentration is influenced by the pace of technological advancements. Companies that invest in research and development to introduce innovative products with enhanced features and efficacy can gain a competitive advantage and increase their market share. Conversely, companies that do not succeed to keep up with technological advancements, risk losing market share to competitors.
The market is witnessing a high degree of innovation, particularly with the development of innovative products for pets. For instance, current developments in CBD-based natural health products have led to various benefits against pain, anxiety, and inflammation in cats & dogs, according to a November 2021 Research in Veterinary Medicine, Elsevier. More veterinary institutes are shifting their studies toward CBD and its potential applications in animal health & wellness. Furthermore, key companies are involved in R&D initiatives to expand their product portfolios. For instance, in August 2022, Pet Releaf introduced a CBD grooming product line for dogs, which includes Skin and Coat Releaf shampoo. As numerous people around the world are adopting pets, the need for CBD has also increased as these animals are becoming cherished family members.
The market is experiencing an increase in collaboration and partnership activities by key players to expand the distribution network. For instance, In May 2023, Charlotte’s Web, Inc. expanded its distribution network through a partnership with Phillips Pet Food & Supplies, America’s largest distributor in the pet specialty retail sector. This collaboration aimed to enhance access to Charlotte’s Web’s CBD pet products, including specialized formulations such as calming aids and joint support chews, across over 6,000 retail locations nationwide.
Regulations significantly impact the market by restricting product approvals and market entry. In the U.S., lack of FDA approval hampers widespread availability, while strict regulations in Europe and Canada limit legal products to those meeting specific safety and efficacy standards. Conversely, evolving regulations in regions like Brazil and India create growth opportunities for compliant products. This shows how regulatory frameworks shape market dynamics.
Product substitutes in the market include traditional pharmaceuticals, natural supplements, and herbal remedies. These alternatives, such as valerian root, chamomile, and prescription medications for anxiety and pain, offer similar benefits without the regulatory complexities associated with the products. They can serve as viable options for pet owners seeking effective treatments.
End-users' preferences for CBD concentrations have a notable impact on the pet market. Those favoring higher concentrations seek enhanced therapeutic benefits, affecting both demand and pricing. Conversely, lower concentrations can appeal to pet owners who are more cautious about dosage or new to CBD products. These preferences shape market dynamics, guiding product formulation strategies and market segmentation to meet varying consumer requirements.
The dogs segment held the largest revenue share of 65.05% of the market in 2023. One of the key factors responsible for this high share is the wide acceptability of CBD products for dogs to treat painful conditions such as osteoarthritis, hip dysplasia, or other chronic diseases.
For instance, Cornell conducted one of the earliest studies, which revealed that CBD helped many canines manage their pain. In the trial, a decrease in pain was observed in more than 80% of the dogs with osteoarthritis, allowing them to be more comfortable and active. Moreover, multiple research studies demonstrated that as a natural supplement, CBD is therapeutically effective and has minimal adverse effects. Therefore, this new approach to treatment is one of the fastest-growing health trends in dogs.
Cats are the second-most popular choice as pets. The segment is projected to be driven by growing concern over the health & immunity of cats and the rising usage of CBD oils to increase comfort, relieve ailments, & boost the overall quality of life. The younger generation, especially millennials, have become aware of maintaining the health of their cats.
Moreover, according to the 2022 American Pet Products Association, roughly 69 million households in the U.S. had cats. The younger generations, especially millennials, were more likely to own them. Leading players are investing heavily in feline-related R&D due to the rapidly increasing adoption of cats and the growing need for their medications. Pet cats can exhibit signs of anxiety and stress in a variety of situations. In these cases, oils can be a natural way to reduce anxiety without any adverse effects. Veterinarians and pet parents consider CBD to be extremely safe for cats.
The e-commerce segment held the largest revenue share of 42.32% in 2023. It provides the convenience of choosing products from various ranges and quantities at a comparative price. In addition, there are lucrative opportunities for segment growth owing to an increase in the usage of smartphones for purchasing pet medical products. These channels also help pet owners avoid physically going to the store and eliminate traveling time, as well as associated expenses. The seasonal discount options available on e-commerce websites have added benefits. Hence, the growing preference for online shopping due to convenience and the booming e-commerce industry are expected to drive the segment growth.
The other distribution channels comprise hospitals & veterinary clinics, which are expected to gain more popularity for offering CBD products in the near future. As veterinary hospitals & clinics are the primary healthcare facilities, anyone in need of medical care prefers receiving treatment and recommended medications from licensed veterinarians. However, according to the American Veterinary Medical Association, the U.S. federal law does not allow U.S. veterinarians to prescribe cannabis or related products for animals.
But according to American Kennel Club, frequent changes in laws is expected to be eased in some areas of the country. Countries such as Australia allow veterinarians to prescribe CBD products for specific conditions. For instance, CBD Vets Australia is the first Australian veterinary clinic where pets are legally prescribed medicinal cannabis & CBD oils by registered veterinary practitioners.
The joint pain segment held the largest revenue share of 28.73% in 2023. CBD is widely used for reducing joint pain and improving the quality of a pet’s life. Joint pain can have many causes such as arthritis, overworking, trauma, and hip dysplasia, among others. The pain causes pets to be reluctant to move, making joints stiffer.
When CBD oils are massaged topically, the skin absorbs the oil and activates the endocannabinoid system, which regulates pain sensations in animals, thereby reducing the pain caused due to arthritis & sore joints. CBD also interacts with receptors in the skin, muscles, and nerves of pets to relieve any physical pain. Therefore, oils, supplements, and mobility chews are widely purchased by pet owners to support their pets suffering from joint pain.
Anxiety/Stress segment is estimated to grow at the highest CAGR from 2024 to 2030. Anxiety or stress is as common in animals as in humans. They display anxious responses, fears, or phobias associated with the environment, objects, sounds, other animals, and people.
Some common symptoms displayed by an anxious or stressed animal are increased vigilance, panting, compulsive behavior, changed sleep patterns, unusual barking, drooling, restlessness, destructive behaviors, urination, and depression. According to a survey conducted in May 2022 by Green Element, a company supplying CBD, anxiety rates among U.S. pet dogs caused by other cats or dogs increased to 43.5% in 2022 from 16.5% in 2020.
North America CBD pet market dominated the overall market with a share of 40.22% in 2023. The dominance is attributed to the advanced healthcare infrastructure, high pet ownership rates, increasing expenditure on animal health, and increased benefits of cannabis, coupled with high awareness among owners. The rising legalization of cannabis for medical purposes in the U.S., coupled with favorable government regulations, is increasing opportunities for pet market players.
Furthermore, an overall increase in the acceptance of cannabidiol for pet care, pharmaceuticals, and wellness is expected to fuel market growth. The market growth can also be attributed to the increasing R&D activities of major CBD pet companies. These companies launch new products and increase strategic collaborations with other market players. In addition, multiple owners are moving toward pet parenting from pet ownership, which in turn is boosting the CBD pet market growth.
The CBD pet market in the U.S. accounted for the largest share in 2023. The market in the country is anticipated to grow due to the increasing demand for natural & organic pet products such as CBD-infused oils, treats, and other products. For instance, in the U.S., 65% of pet owners utilized CBD for their animals in 2023. Moreover, the market growth is fueled by high spending on pet food & treats, care procedures, and pet supplies.
Pet owners in the U.S. spent USD 64.4 billion on pet food and treats in 2023, as per the report by the American Pet Products Association. The growth of the CBD pet market has been positively impacted by the presence of significant market players such as Pet Releaf and Petco Animal Supplies, Inc. These companies are focusing on launching new products and forming strategic alliances. As pet supplements are gaining popularity and are being readily accepted, the players are anticipated to have tremendous growth opportunities.
The Europe CBD pet market is gaining popularity due to the approval or authorization of CBD in most European countries. According to the European Food Safety Authority (EFSA), CBD qualifies as a novel food. Moreover, the European Union (EU) states that CBD products are legal for consumption and storage because there are no known health hazards. Such factors are fueling the growth of the regional pet CBD market. Increasing pet healthcare awareness is driving market growth.
Furthermore, the substantial number of insured pets is supporting the European market growth. For instance, 90% of dogs in Sweden have insurance, as per the North American Pet Health Insurance Association. In addition, trade organizations such as the European Free Trade Association (EFTA) among Liechtenstein, Iceland, Norway, & Switzerland have facilitated trade between countries and increased growth opportunities in the region.
The CBD pet market in Germany is driven by presence of huge number of companion animals in Europe. A recent report by the Central Association of Zoological Specialist Companies (ZZF) stated, 45% of German households own at least one pet in 2023. Cats remained the most popular pets, residing in 25% of homes, Dogs followed closely, with 21% of households. Based on a survey of 5,000 households conducted by Skopos for the Pet Supplies Industry Association (IVH) eV and ZZF, the report indicated that pets are a significant part of German life. This indicates the country's potential need for CBD products for pets. Moreover, several German companies, such as Hanf Farm and CBD Pet GmbH, have launched new CBD pet products in 2023, including CBD oils, treats, and supplements for dogs, cats, & horses.
In addition, the German market is driven by factors such as increasing consumer awareness, acceptance of CBD's potential health benefits for pets, and growing investments to expand CBD platforms in the country. For instance, companies like Cannaable are expanding their presence in Europe, including Germany, through significant investments, which could significantly contribute to market growth. Cannaable, Germany's largest CBD and hemp marketplace, has rapidly grown its platform to include over 160 hemp merchants offering approximately 2,700 products, including successful categories like CBD oils and pet CBD products. Cannaable not only provides a diverse selection of CBD and hemp products but also supports education & marketing efforts, enhancing accessibility and market growth.
The UK CBD pet market is expected to grow at lucrative CAGR from 2024 to 2030. An increase in pet ownership and pet insurance is contributing to market growth. Approximately 53% of UK households owned pets in 2023, with 29% of these pets being dogs, according to FEDIAF. Furthermore, pets are increasingly getting insured due to the prevalence of pet diseases. About 25% to 30% of pets were insured in the country. Although growing, possessing, or distributing cannabis was banned in the country, the use of medical cannabis was approved in 2018. Furthermore, it is not essential to have a doctor's prescription to use or trade CBD oil in the country. This is expected to drive the growth of the country's CBD pet market.
The CBD pet market in Asia Pacific is expected to grow rapidly from 2024 to 2030. The region's market is expanding due to factors such as the increasing authorization of CBD in various countries and supportive government initiatives by Thailand, South Korea, & Australia for the use of CBD. Moreover, since 2016, medical cannabis has been allowed in Australia. To promote the cannabis market, the federal government authorized the export of medical cannabis in 2018. Consequently, the country's CBD companies are now allowed to cultivate, manufacture, and sell cannabis. Furthermore, the presence of organizations such as PETstock creates a potential for growth. Such supportive factors are propelling the Asia Pacific CBD pet market.
Japan CBD pet market is growing owing to rising aging population, as pets, are considered good companions for the elderly; the use of organic or natural materials for manufacturing pet products like CBD oils by manufacturers; and growing pet ownership, leading to increased spending on service packages with more options, including CBD products. The CBD market is expanding despite the strict legal frameworks, and high-quality CBD products are available in major cities such as Tokyo.
Moreover, Japanese market is fueled by government approvals that promote and permit the use of cannabis. The Japanese government allowed the use of CBD in its provinces in 2016, which helped the CBD pet market grow. Another contributing factor is the Japanese culture's use of herbal remedies to address various medical conditions. These factors are expected to propel market growth shortly.
The CBD pet market in India is anticipated to grow from 2024 to 2030 due to the presence of companies, such as CBD Oil Store India and Endoca, that offer home delivery of pet care products. Furthermore, the market is growing due to online distribution through e-commerce platforms such as Amazon India, which provides CBD products for dogs and other pet animals.
The increased advantages of cannabis, combined with high awareness among owners, are fueling the market growth. Most pet owners prefer the traditional method of CBD administration since it is the most effective and convenient. Purchasing CBD for pets in India through specialized online platforms is the fastest and most practical method. Since CBD products are currently unavailable in retail and medical stores, ordering them online from reliable, trustworthy sources is the best option.
The Latin America CBD pet market is anticipated to expand from 2024 to 2030. Decriminalization of cannabis, therapeutic properties of CBD, and domestic hemp production are some of the factors driving the growth of the Latin America market. Moreover, the regional market is growing due to increasing government initiatives to legalize the industry.
In addition, the anticipated increase in demand for CBD in medicinal treatments, along with the promotion of more accessible regulatory laws by international market participants, is expected to drive market growth. In LATAM and Caribbean countries, the legalization of cannabis has increased. The country's authorities have conducted a long campaign to decriminalize marijuana usage while combating the widespread illegal marijuana trade. Many countries have allowed its usage for medical purposes.
The CBD pet market in Brazil is expected to grow from 2024 to 2030. The Brazilian Chamber of Deputies received a bill (369/2021) allowing veterinarians to prescribe cannabis products. The bill requires that products be approved by Brazilian regulatory authorities or, in the case of imported products, their equivalent in the country of origin. The bill states that products must adhere to current restrictions for human-use products if the government does not adopt separate regulations for veterinary products. Since 2014, doctors have been permitted to prescribe cannabis products for medical purposes.
However, cultivation is still prohibited. The prescription of cannabis products is allowed once a patient has completed all other available alternative treatments. Products containing more than 0.2 percent THC can only be recommended for supportive care to patients who have no other therapeutic options and are in an irreversible or terminal clinical condition. Furthermore, CBD pet products are widely available in Brazil, both online and in pet stores. This accessibility has contributed to the market growth, as pet owners can easily find and purchase CBD products for their pets.
The MEA CBD pet market is driven by rising adoption rates of companion animals and increasing awareness among pet owners. Increasing government efforts to support animal healthcare facilities are anticipated to drive the market in this region. However, it is expected that a complex regulatory framework for cannabis use, and cannabis-related myths may restrict market expansion. The cannabis market is expected to face challenges from intensive energy use and problems maintaining product uniformity for cannabis cultivation. However, pet owners are becoming increasingly aware of the possible advantages of CBD (cannabidiol) for their animals. This includes its claimed advantages for treating inflammation, pain, anxiety, and other ailments in animals.
The CBD pet market in Saudi Arabia is growing stagnantly as there are several restrictions regarding CBD, including a lack of research on cannabis' potential medical applications, legal & ethical prohibition of its usage, and a lack of funding for such studies. Arab and Middle Eastern countries continue to ban the use of cannabis and cannabis-derived products completely. The Arab countries might legalize cannabis in the future as the use of cannabis expands globally to meet medical needs and provide additional treatment options for certain diseases or ailments. Moreover, rising investments in pet care products are expected to drive the market.
Major players in the market are actively engaged in competitive and highly fragmented market dynamics. These companies emphasize R&D along with introducing new products to enhance their market presence. Furthermore, they are frequently collaborating with pet stores, and e-commerce platforms to expand their geographical presence as well as to strengthen their distribution network. They are also expanding globally to tap into emerging markets and influence the increasing awareness and acceptance of CBD pet products globally.
The following are the leading companies in the CBD pet market. These companies collectively hold the largest market share and dictate industry trends.
In September 2023, Pet Releaf introduced a concentrated professional cbd shampoo and travel size shampoos & conditioners at SuperZoo 2023. These new offerings emphasize plant-based, natural ingredients, targeting professional groomers and pet care businesses.
In May 2023, Charlotte's Web expanded its distribution network through a partnership with Phillips Pet Food & Supplies, America's largest distributor in the pet specialty retail sector. This collaboration aims to enhance access to Charlotte's Web's CBD pet products, including specialized formulations like calming aids and joint support chews, across over 6,000 retail locations nationwide.
Report Attribute |
Details |
Market size value in 2024 |
USD 318.0 million |
Revenue Forecast in 2030 |
USD 1.72 billion |
Growth Rate |
CAGR of 32.47% from 2024 to 2030 |
Actual data |
2018 - 2023 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments Covered |
Animal type, indication, distribution channel, region, |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia. |
Key companies profiled |
Honest Paws LLC; Canna-Pet LLC; Laboratoire Francodex; Pet Releaf; HolistaPet; Joy Organics; Wet Noses Natural Dog Treat Co.; CBD Living; PETstock; Garmon Corp.; Charlotte’s Web, Inc.; Green Roads; HempMy Pet; FOMO Bones |
Customization scope |
Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global CBD pet market report based on animal type, indication, distribution channel, and region.
Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Dogs
Foods/Treats
Vitamins & supplements
Cats
Foods/Treats
Vitamins & supplements
Others
Indication Outlook (Revenue, USD Million, 2018 - 2030)
Joint Pain
Anxiety/Stress
Epilepsy
General Health/Wellness
Other Indications
Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Pet Specialty Stores
E-commerce
CBD Store
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
South Korea
Australia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
Rest of Middle East & Africa
b. The global CBD pet market size was estimated at USD 248.39 million in 2023 and is expected to reach USD 318.0 million in 2024.
b. The global CBD pet market is expected to grow at a compound annual growth rate of 32.47% from 2024 to 2030 to reach USD 1.72 billion by 2030.
b. The North America region dominated the CBD pet market in 2023 with a share of over 40.22%. The increased benefits of cannabis coupled with high awareness among owners are driving the market growth. Furthermore, an overall increase in the acceptance of cannabidiol for pet care, pharmaceutical, and wellness purposes is expected to fuel the market growth. The market growth can also be attributed to the increasing R&D activities conducted by major CBD pet companies.
b. Some key players operating in the CBD pet market include Honest Paws; Canna-Pet; FOMO Bones; Pet Releaf; HolistaPet; Joy Organics; Wet Noses Natural Dog Treat Co.; CBD Living; PETstock; Petco Animal Supplies, Inc.; Charlotte’s Web; Green Roads; and HempMy Pet.
b. The market is primarily driven by rising R&D initiatives, increasing demand, pet humanization, and expenditure.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."